These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1029986

  • 1. [Clinical and experimental studies on the angiotensin inhibitor 1-sar-8-ile-angiotensin II (P 165)].
    Werner U, Waelsch I, Bock KD.
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1310-3. PubMed ID: 1029986
    [No Abstract] [Full Text] [Related]

  • 2. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K, Fujishima S, Shionoiri H, Tochikubo O, Uneda S, Fujiki Y, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
    [No Abstract] [Full Text] [Related]

  • 3. Angiotensin II blockade in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):61-3. PubMed ID: 1071407
    [No Abstract] [Full Text] [Related]

  • 4. Physiologic studies with saralasin in animals.
    Gavras H, Gavras I, Brunner HR, Liang CS.
    Kidney Int Suppl; 1979 Mar; (9):S20-8. PubMed ID: 384069
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of saralasin on blood pressure, plasma renin and plasma noradrenaline in hypertensive patients].
    Bönner G, Lang R, Hummerich W, Helber A, Meurer KA, Wambach G, Kaufmann W.
    Med Welt; 1980 Sep 19; 31(38):1362, 1363-5. PubMed ID: 7001167
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Blood pressure behavior following 1-sar-8-ala-angiotensin II (saralasin) in essential and renovascular hypertension].
    Rosenthal J, Franz HE.
    Verh Dtsch Ges Inn Med; 1976 Sep 19; 82 Pt 2():1305-7. PubMed ID: 1029984
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hemodynamic correlates of saralasin: responsiveness in hypertension.
    Kem DC, Frohlich ED, de Carvalho JG, Dunn FG, Chrysant SG, Danisa K, Wambach G.
    Kidney Int Suppl; 1979 Mar 19; (9):S68-74. PubMed ID: 289866
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T, Nakamaru M, Higaki J, Hata T, Kumagai A, Kumahara Y.
    Med J Osaka Univ; 1983 Sep 19; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract] [Full Text] [Related]

  • 12. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG, Parker FB, Poirier RA, Anderson G, Streeten DH, Blackman M.
    Surg Forum; 1979 Sep 19; 30():189-90. PubMed ID: 395680
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M, Passalacqua W, Plaza de los Reyes X, Pla C, Campino C.
    Rev Med Chil; 1980 Feb 19; 108(2):115-20. PubMed ID: 7017869
    [No Abstract] [Full Text] [Related]

  • 14. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA, Dawes PM.
    Aust N Z J Med; 1976 Aug 19; 6(3 Suppl):53-4. PubMed ID: 1071404
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the ability of two angiotensin II receptor blocking drugs, 1-Sar; 8-Ala angiotensin II and 1-Sar, 8-Ile angiotensin II, to modify the regulation of glomerular filtration rate in the cat.
    Johns EJ.
    Br J Pharmacol; 1980 Aug 19; 71(2):499-506. PubMed ID: 7470759
    [Abstract] [Full Text] [Related]

  • 17. Physiologic determinants and clinical applications of angiotensin II blockade in hypertensive disorders.
    Parra-Carrillo JZ, Baer L, Radichevich I.
    Cardiovasc Clin; 1978 Aug 19; 9(1):183-95. PubMed ID: 667880
    [No Abstract] [Full Text] [Related]

  • 18. Response to saralasin and angiotensin's role in essential and renal hypertension.
    Hollenberg NK, Williams GH, Adams DF, Moore T, Brown C, Borucki LJ, Leung F, Bavli S, Solomon HS, Passan D, Dluhy R.
    Medicine (Baltimore); 1979 Mar 19; 58(2):115-27. PubMed ID: 431398
    [No Abstract] [Full Text] [Related]

  • 19. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N, Buemi M, Lasco A, Macrí I, Ciraolo O, Nicita Mauro V, Costa G.
    Boll Soc Ital Biol Sper; 1980 Jul 15; 56(13):1367-73. PubMed ID: 7004464
    [Abstract] [Full Text] [Related]

  • 20. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
    Fagard R, Amery A, Lijnen P, Reybrouck T, Joossens JV, Billiet L, Moerman E, De Schaepdryver A.
    Clin Exp Pharmacol Physiol; 1978 Jul 15; 5(5):457-64. PubMed ID: 729204
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.